. The pressure will be on Nishar, and his cohort of biotechnology and life sciences portfolio companies, to avoid public spectacle and continue building companies that could become the arbiters of Nishar's new internet.He and his cofounder Joseph Yen moved out to San Francisco from Boston in 2000 to work on the company, which made enterprise software predating the now-ubiquitous cloud infrastructure. After the market crashed following September 11, 2001, the company was in trouble.
In addition to 10x Genomics and Seer, Nishar has invested in tens of companies in biotech and life sciences that he said represent every piece of the drug discovery and development process. Nishar's strategy has run counter to other investors' at SoftBank, which are known to back several startups in the same industry in the hopes that one will ultimately become successful. The practice is fairly common among venture capitalists because most startups ultimately fail.Both Farokhzad and Saxanov said that they took particular pride in catching Nishar's attention as an investor.
Finance Finance Latest News, Finance Finance Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Reuters - 🏆 2. / 97 Read more »